FdaApprovalPulse: Drug efficacy supplement (new indication or use), page 2 of 2
Records 51 to 77 of the 77 newest listed for this hub. Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration).
| Record | Product | Approval | Decided |
|---|---|---|---|
| NOVARTIS | KISQALI | Drug efficacy supplement (new indication or use) | 2026-07-01 |
| NOVARTIS | KISQALI FEMARA CO-PACK (COPACKAGED) | Drug efficacy supplement (new indication or use) | 2026-07-01 |
| ARCUTIS | ZORYVE | Drug efficacy supplement (new indication or use) | 2026-06-29 |
| ABBVIE INC | SKYRIZI | Drug efficacy supplement (new indication or use) | 2026-06-26 |
| IMMUNOMEDICS INC | TRODELVY | Drug efficacy supplement (new indication or use) | 2026-06-24 |
| IMMUNOMEDICS INC | TRODELVY | Drug efficacy supplement (new indication or use) | 2026-06-24 |
| IONIS PHARMS INC | TRYNGOLZA (AUTOINJECTOR) | Drug efficacy supplement (new indication or use) | 2026-06-24 |
| PFIZER | IBRANCE | Drug efficacy supplement (new indication or use) | 2026-06-24 |
| PFIZER | IBRANCE | Drug efficacy supplement (new indication or use) | 2026-06-24 |
| AMPHASTAR PHARMS INC | REXTOVY | Drug efficacy supplement (new indication or use) | 2026-06-16 |
| ABBVIE INC | SKYRIZI | Drug efficacy supplement (new indication or use) | 2026-06-12 |
| ASTRAZENECA | TRUQAP | Drug efficacy supplement (new indication or use) | 2026-06-12 |
| PROVENTION BIO INC | TZIELD | Drug efficacy supplement (new indication or use) | 2026-06-12 |
| ELI LILLY AND CO | EBGLYSS | Drug efficacy supplement (new indication or use) | 2026-06-09 |
| PFIZER INC | HYMPAVZI | Drug efficacy supplement (new indication or use) | 2026-06-05 |
| MANNKIND | AFREZZA | Drug efficacy supplement (new indication or use) | 2026-05-29 |
| ASTRAZENECA UK LTD | IMFINZI | Drug efficacy supplement (new indication or use) | 2026-05-28 |
| ACTELION | UPTRAVI | Drug efficacy supplement (new indication or use) | 2026-05-23 |
| DAIICHI SANKYO INC | DATROWAY | Drug efficacy supplement (new indication or use) | 2026-05-22 |
| ABBVIE | LINZESS | Drug efficacy supplement (new indication or use) | 2026-05-21 |
| ABBVIE | VENCLEXTA | Drug efficacy supplement (new indication or use) | 2026-05-20 |
| INCYTE CORP | ZYNYZ | Drug efficacy supplement (new indication or use) | 2026-05-18 |
| GENENTECH INC | TECENTRIQ HYBREZA | Drug efficacy supplement (new indication or use) | 2026-05-15 |
| GENENTECH INC | TECENTRIQ | Drug efficacy supplement (new indication or use) | 2026-05-15 |
| TAIHO ONCOLOGY | INQOVI | Drug efficacy supplement (new indication or use) | 2026-05-13 |
| CUBIST PHARMS LLC | ZERBAXA | Drug efficacy supplement (new indication or use) | 2026-05-12 |
| GENENTECH INC | OCREVUS | Drug efficacy supplement (new indication or use) | 2026-05-08 |
All FdaApprovalPulse record reports